CD52 is a small glycopeptide expressed on the cell surface of normal and malignant T lymphocytes, along with other leukocytes (7).Elevated CD52 expression on CD4+ T lymphocytes, the main circulating cell in SS, makes this molecule an applicable target (8). Here, CD52 is linked to synovial sarcoma.